Skip to main content

Table 1 Basic clinical information, serum levels and positive rates of ANCA and ASCA of the patients and controls

From: Assessment of clinical activity and severity using serum ANCA and ASCA antibodies in patients with ulcerative colitis

Patients groupsNMaleFemaleMale:FemaleAverage of age (yrs)ANCA-IgGASCA-IgAASCA-IgG
N (%)N (%)N (%)
Healthy controls10054461:0.8553.19 ± 14.853.15 ± 2.241.16 ± 1.493.41 ± 5.41
6 (6)7 (7)8 (8)
Disease controls5228241:0.8650.88 ± 14.014.03 ± 5.960.95 ± 1.942.38 ± 3.16
7 (13.5)3 (5.77)1 (1.92)
UC10552531:1.0247.33 ± 15.4317.5 ± 30.6a,b2.06 ± 9.184.05 ± 6.42
65 (61.9)a,b11 (10.5)13 (12.4)
  1. Age years with mean ± SD, antibody levels are U/mL (mean ± SD)
  2. aP < 0.05: Compared with healthy controls
  3. bP > 0.05: Compared with disease controls